Unisom SleepMelts, which contains 25mg of diphenhydramine hydrochloride, was developed by Eurand using its AdvaTab and Microcaps taste-masking technologies. The product was developed as part of the EUR-1047 program.
Unisom SleepMelts, an over-the-counter (OTC) sleep-aid, is now available in leading US mass merchandiser, drug and food retailers. Eurand will exclusively supply the product for Chattem, which will be manufactured at Eurand’s US facility in Vandalia, Ohio.
Gearoid Faherty, CEO of Eurand, said: “We are pleased to complete the development and witness the launch of our diphenhydramine orally disintegrating tablet (ODT) product under Chattem’s Unisom brand name. The launch of Unisom SleepMelts represents the first product to be commercialized using our AdvaTab ODT technology and is further evidence of the strength of our drug formulation technology and development capabilities.”